Aspire Biopharma Holdings Inc [NASDAQ: ASBP] closed the trading session at $0.59 on 2025-09-03. The day’s price range saw the stock hit a low of $0.5201, while the highest price level was $0.5871.
The stocks have a year to date performance of -94.68 percent and weekly performance of 10.26 percent. The stock has been moved at -29.08 percent over the last six months. The stock has performed 60.67 percent around the most recent 30 days and changed 52.55 percent over the most recent 3-months.
If compared to the average trading volume of 11.81M shares, ASBP reached to a volume of 13804663 in the most recent trading day, which is why market watchdogs consider the stock to be active.
ASBP stock trade performance evaluation
Aspire Biopharma Holdings Inc [ASBP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.26. With this latest performance, ASBP shares gained by 60.67% in over the last four-week period, additionally sinking by -29.08% over the last 6 months – not to mention a drop of -94.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASBP stock in for the last two-week period is set at 64.35, with the RSI for the last a single of trading hit 0.0756, and the three-weeks RSI is set at 0.0750 for Aspire Biopharma Holdings Inc [ASBP]. The present Moving Average for the last 50 days of trading for this stock 0.4015, while it was recorded at 0.5652 for the last single week of trading, and 4.1561 for the last 200 days.
Aspire Biopharma Holdings Inc (ASBP) Capital Structure & Debt Analysis
Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics
Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics
Aspire Biopharma Holdings Inc [ASBP]: Institutional Ownership
There are presently around $4.67%, or 6.97%% of ASBP stock, in the hands of institutional investors.
